Study halted early: new approach tested to shield kids from transplant complications
NCT ID NCT05579769
Summary
This study tested a new plan for medications given after a bone marrow transplant to prevent a serious complication called graft-versus-host disease (GVHD). It involved children and young adults with blood cancers who received a transplant from a matched donor. The main goal was to see if stopping a specific type of immune-suppressing drug early (after 60 days) could still prevent severe GVHD while potentially reducing side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Conditions
Explore the condition pages connected to this study.